Keywords

MedicineRimonabantAdjunctType 2 diabetesOverweightDiabetes mellitusObesityInternal medicineEndocrinology

Related Publications

Publication Info

Year
2007
Type
article
Volume
28
Issue
11
Pages
1402-1402
Citations
365
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

365
OpenAlex

Cite This

Lars Rydén, Eberhard Standl (2007). Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply. European Heart Journal , 28 (11) , 1402-1402. https://doi.org/10.1093/eurheartj/ehm124

Identifiers

DOI
10.1093/eurheartj/ehm124